CROIVALVE LIMITED

CroíValve Limited is a medical-technology company dedicated to improving outcomes for patients with tricuspid regurgitation, a common yet often under-diagnosed heart condition. Their flagship offering, the DUO™ System, is a minimally invasive valve device that works alongside the native tricuspid valve, helping it function as nature intended. Designed to be tailored to each patient's anatomy, the DUO™ System aims to preserve the heart's native structure while simplifying the procedural learning curve for clinicians.

The company's collective mission is clear: support more than four million individuals across the US and Europe who live with tricuspid regurgitation, shorten treatment pathways, and ultimately extend lives. By providing a solution that integrates seamlessly with existing cardiac anatomy, CroíValve seeks to bring a new era of heart care to both patients and practitioners alike.